Current and future role of biomarkers in Crohn’s disease risk assessment and treatment

BACKGROUND: Crohn’s disease (CD), a chronic inflammatory bowel disease (IBD), occurs in genetically susceptible individuals who develop aberrant immune responses to endoluminal bacteria. Recurrent inflammation increases the risk of several complications. Despite use of a traditional “step-up” therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamboli, Cyrus P, Doman, David B, Patel, Amar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132855/
https://www.ncbi.nlm.nih.gov/pubmed/21753895
http://dx.doi.org/10.2147/CEG.S18187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132855/
https://www.ncbi.nlm.nih.gov/pubmed/21753895
http://dx.doi.org/10.2147/CEG.S18187

Ejemplares similares